Spondyloarthritis & psoriatic arthritis

Comparison of the effect of treatment with non-steroidal anti-inflammatory drug (NSAIDs) added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial

Ann Rheum DisPublished Randomised controlled trial

Authors' conclusion

Combination therapy with GOL+CEL did not demonstrate statistically significant superiority over GOL monotherapy in retarding radiographic spinal progression over 2 years in r-axSpA.

Study context

Population
Radiographic axial spondyloarthritis (r-axSpA) patients with risk factors for radiographic progression (high disease activity plus CRP >5 mg/L and/or ≥1 syndesmophyte(s)) and good clinical response to golimumab (GOL) at week 12128 enrolled in run-in
Participants
109 patients
Comparison
GOL+celecoxib (CEL) 200 mg twice daily vs GOL monotherapy
  • Combination therapyn = 54
  • Monotherapyn = 55reference
Primary endpoint
Radiographic progression: Modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) change, ITT population
Follow-up
Week 108
Methodological details12-week run-in phase with GOL, randomised 1:1 after good clinical response at week 12
  • 12-week run-in phase with GOL
  • Randomised 1:1 after good clinical response at week 12

Primary result

As reported in the abstract

Change in mSASSS

Monotherapy

1.7

95% CI 0.8–2.6

Combination therapy

1.1

95% CI 0.4–1.8

P = 0.79

Further findings

New syndesmophytes

P = 0.12

Safety

Adverse events and serious adverse events · During the study

No significant differences between the groups

Original publication

Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Ann Rheum Dis. Published 11 April 2024. doi:10.1136/ard-2023-224699

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.